SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: Jenna who wrote (4660)1/9/1998 12:57:00 PM
From: AlienTech  Read Replies (1) | Respond to of 120523
 
INPUT/OUTPUT (IO) 20 -5 7/8. Shares of this seismic data acquisition services company are being crushed by a Goldman Sachs downgrade from "recommended list "buy" to "market outperform." The interesting thing about the move, however, is that Goldman continues to be extremely bullish on the company's prospects. According to analyst John Reynolds, near term prospects for the seismic equipment market appear quite positive. And, based on Mr. Reynolds decision to maintain his FY98 earnings estimate of $1.25 and his 1999 view of $1.50, IO's earnings picture has not changed. More than anything else it appears the Goldman analyst is simply attempting to lower his investment rating to a level that would better reflect the less certain near-term outlook for oilfield services stocks given the technical breakdown in the sector. The analyst's new price target of $33 (lowered from $40), suggests upside potential of 65% from the stock's current level. But you can almost be certain that Mr. Reynolds did not expect today's downgrade to have such a pronounced effect on the stock.



To: Jenna who wrote (4660)1/10/1998 11:40:00 AM
From: harryr26  Read Replies (1) | Respond to of 120523
 
Hi Jenna,

Saw that you had MDYN to go down. After coming down to $10 do you think it is oversold now? Are you looking for a bounce or for this to continue down? Thanks.

Harry



To: Jenna who wrote (4660)1/11/1998 2:01:00 AM
From: Vector1  Read Replies (1) | Respond to of 120523
 
Jenna,
Big time call on MDYN. What did you see that I missed. I am new to this thread but I rely on fundemental analysis. MDYN has some very exciting technology including a gene sequencer (MegaBace) which recieved rave reviews from an INCYTE scientist at a genomics conference in the Fall. Its a large market dominated by Perkin Elmer. With a market cap approaching $100m. If MegaBace is sucessful the company should be worth 3 or 4 times its current value.
V1